Dr Matthew Ivory
Teams and roles for Matthew Ivory
Overview
Qualifications
- SFHEA: Advance HE (2024)
- FHEA: Advance HE (2019)
- PhD: School of Pharmacy and Pharmaceutical Sciences, Cardiff University (2016)
- GPhC: Professional registration (2012)
- Pharmacy degree (MPharm): First Class Honours, Cardiff University (2011)
Publication
2025
- Phyfer, R., Deslandes, R. and Ivory, M. 2025. Diversification of MyDispense in Wales: improving representation and the student experience [Abstract]. Presented at: 11th Biennial Monash Pharmacy Education Symposium 2024, Prato, Italy, 7-10 July 2024Monash Pharmacy Education Symposium Abstracts, Vol. 25. Vol. 3. pp. 24-25.
- Gray, L. et al. 2025. Trends in tricyclic antidepressant prescribing and poisoning in England and Wales 2016-2020. British Journal of Clinical Pharmacology 91(6), pp. 1727-1738. (10.1111/bcp.16400)
2024
- Hughes, L., Bowen, J., Davies, W., Deslandes, R., Ivory, M. and Kingman, S. 2024. When pharmacy and theater collide: How diversity can develop inclusive communication skills. Currents in Pharmacy Teaching and Learning 16(6), pp. 460-464. (10.1016/j.cptl.2024.03.005)
2019
- Maarifi, G. et al. 2019. Langerin (CD207) represents a novel interferon-stimulated gene in Langerhans cells. Cellular and Molecular Immunology 17, pp. 547-549. (10.1038/s41423-019-0302-5)
2016
- Czubala, M. A. et al. 2016. TGFβ induces a SAMHD1-independent post-entry restriction to HIV-1 infection of human epithelial Langerhans cells. Journal of Investigative Dermatology 136(10), pp. 1981-1989. (10.1016/j.jid.2016.05.123)
- Caucheteux, S. M. et al. 2016. Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1. Journal of Investigative Dermatology 136(6), pp. 1172-1181. (10.1016/j.jid.2016.01.033)
- Ivory, M. O. 2016. Characterising skin immune cells to inform development of intradermal vaccines and therapeutics. PhD Thesis, Cardiff University.
2015
- Ivory, M. O., Birchall, J. C. and Piguet, V. 2015. Early dengue virus infection in human skin: a cycle of inflammation and infectivity [Commentary]. Journal of Investigative Dermatology 135(7), pp. 1711-1712. (10.1038/jid.2014.544)
2010
- Pearton, M. et al. 2010. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28(37), pp. 6104-6113. (10.1016/j.vaccine.2010.05.055)
- Pearton, M., Kang, S. M., Song, J. M., Anstey, A. V., Ivory, M. O., Compans, R. W. and Birchall, J. C. 2010. Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS ONE 5(8), article number: e12410. (10.1371/journal.pone.0012410)
Articles
- Gray, L. et al. 2025. Trends in tricyclic antidepressant prescribing and poisoning in England and Wales 2016-2020. British Journal of Clinical Pharmacology 91(6), pp. 1727-1738. (10.1111/bcp.16400)
- Hughes, L., Bowen, J., Davies, W., Deslandes, R., Ivory, M. and Kingman, S. 2024. When pharmacy and theater collide: How diversity can develop inclusive communication skills. Currents in Pharmacy Teaching and Learning 16(6), pp. 460-464. (10.1016/j.cptl.2024.03.005)
- Maarifi, G. et al. 2019. Langerin (CD207) represents a novel interferon-stimulated gene in Langerhans cells. Cellular and Molecular Immunology 17, pp. 547-549. (10.1038/s41423-019-0302-5)
- Czubala, M. A. et al. 2016. TGFβ induces a SAMHD1-independent post-entry restriction to HIV-1 infection of human epithelial Langerhans cells. Journal of Investigative Dermatology 136(10), pp. 1981-1989. (10.1016/j.jid.2016.05.123)
- Caucheteux, S. M. et al. 2016. Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1. Journal of Investigative Dermatology 136(6), pp. 1172-1181. (10.1016/j.jid.2016.01.033)
- Ivory, M. O., Birchall, J. C. and Piguet, V. 2015. Early dengue virus infection in human skin: a cycle of inflammation and infectivity [Commentary]. Journal of Investigative Dermatology 135(7), pp. 1711-1712. (10.1038/jid.2014.544)
- Pearton, M. et al. 2010. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28(37), pp. 6104-6113. (10.1016/j.vaccine.2010.05.055)
- Pearton, M., Kang, S. M., Song, J. M., Anstey, A. V., Ivory, M. O., Compans, R. W. and Birchall, J. C. 2010. Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines. PLoS ONE 5(8), article number: e12410. (10.1371/journal.pone.0012410)
Conferences
- Phyfer, R., Deslandes, R. and Ivory, M. 2025. Diversification of MyDispense in Wales: improving representation and the student experience [Abstract]. Presented at: 11th Biennial Monash Pharmacy Education Symposium 2024, Prato, Italy, 7-10 July 2024Monash Pharmacy Education Symposium Abstracts, Vol. 25. Vol. 3. pp. 24-25.
Thesis
- Ivory, M. O. 2016. Characterising skin immune cells to inform development of intradermal vaccines and therapeutics. PhD Thesis, Cardiff University.
Research
Following completion of my MPharm degree and pre-registration training year working across the industrial, hopsital and community pharmacy sectors, I undertook a PhD in drug delivery. My early research interests included formulation science, drug delivery and the development of ex vivo skin tissue and cell models. This training in pharmaceutical sciences and pharmacy practice continues to underpin and inform my teaching across the MPharm.
More recently, my research has taken on a more clinical and health economics focus. Recent research projects have been completed in collaboration with:
- All Wales Toxicology and Therapeutics Centre
- Cardiff and Vale University Health Board
- Health Education and Improvement Wales
- Hywel Dda University Health Board
- National Poisons Information Service
- Tillotts Pharma UK
I am also currently undertaking pedagogical research in the area of clinical simulation, with particular focus on the use of Monash University's MyDispense platform for which I am the head of the national MyDispense UK Community and a member of the international steering group for the biennial Global MyDispense Symposium.
Teaching
MPharm undergraduate teaching
- PH1122 - The Role of The Pharmacist in Professional Practice
- PH2107 - Formulation Science I (module leader)
- PH3110 - Optimisation of Pharmaceutical Care
- PH3114 - Design, Formulation and Quality Assurance of Medicinal Products
- PH4116 - Pharmacy Research or Scholarship Project (member of the module leadership team)
- PH4118 - Pharmaceutical Sciences, Pharmacy Practice and the Patient
Biography
Career profile
- July 2016 - Present: Lecturer, School of Pharmacy and Pharmaceutical Sciences, Cardiff University.
- September 2015 - October 2015: Visiting Researcher, Department of Immunology and Cell Biology, Osaka University, Japan.
- October 2012 - September 2016: Postgraduate Research Student, School of Pharmacy and Pharmaceutical Sciences, Cardiff University.
- Aug 2012 - Nov 2023: Locum Pharmacist, various locations.
- Aug 2011 - Jul 2012: Pre-Registration Pharmacist, Bristol-Myers Squibb and St Helens and Knowsley Teaching Hospitals NHS Trust, Merseyside.
- September 2007 - July 2011: Undergraduate Student (MPharm), School of Pharmacy and Pharmaceutical Sciences, Cardiff University.